M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics

Documenti analoghi

• M‐Atrial Natriuretic Peptide and Nitroglycerin in a Canine Model of Experimental Acute Hypertensive Heart Failure: Differential Actions of 2 cGMP Activating Therapeutics
  di: McKie, Paul M., et al.
  Pubblicazione: (2014)
• A NOVEL ATRIAL NATRIURETIC PEPTIDE BASED THERAPEUTIC IN EXPERIMENTAL ANGIOTENSIN II MEDIATED ACUTE HYPERTENSION
  di: McKie, Paul M., et al.
  Pubblicazione: (2010)
• Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator Which Goes Beyond Atrial and B-type Natriuretic Peptides
  di: Ichiki, Tomoko, et al.
  Pubblicazione: (2015)
• Predictive Utility of Atrial, N-Terminal Pro-Atrial, and N-Terminal Pro-B-Type Natriuretic Peptides for Mortality and Cardiovascular Events in the General Community: A 9-Year Follow-up Study
  di: McKie, Paul M., et al.
  Pubblicazione: (2011)
• Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis
  di: Ichiki, Tomoko, et al.
  Pubblicazione: (2013)